112 related articles for article (PubMed ID: 16109117)
1. Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis.
Green MW; Giordano S; Jiang P; Jafari M; Smith TB
Headache; 2005 Sep; 45(8):1031-7. PubMed ID: 16109117
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
Blumenfeld AM; Schim JD; Chippendale TJ
Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
[TBL] [Abstract][Full Text] [Related]
4. Divalproex sodium in the treatment of migraine and cluster headaches.
Gallagher RM; Mueller LL; Freitag FG
J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
8. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F
J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine.
Caruso JM; Brown WD; Exil G; Gascon GG
Headache; 2000 Sep; 40(8):672-6. PubMed ID: 10971664
[TBL] [Abstract][Full Text] [Related]
11. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
Apostol G; Cady RK; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
Headache; 2008 Jul; 48(7):1012-25. PubMed ID: 18705027
[TBL] [Abstract][Full Text] [Related]
12. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group.
Silberstein SD; Collins SD
Headache; 1999 Oct; 39(9):633-43. PubMed ID: 11284461
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
15. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
[TBL] [Abstract][Full Text] [Related]
17. A preliminary controlled trial of divalproex in posttraumatic stress disorder.
Hamner MB; Faldowski RA; Robert S; Ulmer HG; Horner MD; Lorberbaum JP
Ann Clin Psychiatry; 2009; 21(2):89-94. PubMed ID: 19439158
[TBL] [Abstract][Full Text] [Related]
18. Headache prevention outcome and body mass index.
Bigal ME; Gironda M; Tepper SJ; Feleppa M; Rapoport AM; Sheftell FD; Lipton RB
Cephalalgia; 2006 Apr; 26(4):445-50. PubMed ID: 16556246
[TBL] [Abstract][Full Text] [Related]
19. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
